l 670596 has been researched along with gamma-linolenic acid in 1 studies
Studies (l 670596) | Trials (l 670596) | Recent Studies (post-2010) (l 670596) | Studies (gamma-linolenic acid) | Trials (gamma-linolenic acid) | Recent Studies (post-2010) (gamma-linolenic acid) |
---|---|---|---|---|---|
21 | 0 | 0 | 1,300 | 216 | 275 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beauchamp, MH; Bernier, SG; Chemtob, S; Gobeil, F; Hou, X; Kanai, K; Lepage, G; Morrow, JD; Roberts, LJ; Taber, DF; Varma, DR | 1 |
1 other study(ies) available for l 670596 and gamma-linolenic acid
Article | Year |
---|---|
2,3-Dinor-5,6-dihydro-15-F(2t)-isoprostane: a bioactive prostanoid metabolite.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Brain; Calcium; Calcium Channel Blockers; Carbazoles; Dinoprost; Endothelium, Vascular; Enzyme Inhibitors; F2-Isoprostanes; gamma-Linolenic Acid; Humans; In Vitro Techniques; Microcirculation; Prostaglandin Antagonists; Pyridines; Retinal Vessels; Swine; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents | 2001 |